\BOOKMARK [0][-]{section*.4}{List of Figures}{}% 1
\BOOKMARK [0][-]{section*.6}{List of Tables}{}% 2
\BOOKMARK [0][-]{section*.9}{List of Abbreviations}{}% 3
\BOOKMARK [0][-]{section*.11}{List of Terms}{}% 4
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 5
\BOOKMARK [1][-]{section.1.1}{Overview}{chapter.1}% 6
\BOOKMARK [1][-]{section.1.2}{tRNA and disease}{chapter.1}% 7
\BOOKMARK [1][-]{section.1.3}{tRNA biogenesis}{chapter.1}% 8
\BOOKMARK [1][-]{section.1.4}{tRNA sequencing}{chapter.1}% 9
\BOOKMARK [1][-]{section.1.5}{Previous efforts for genome-wide tRNA annotation}{chapter.1}% 10
\BOOKMARK [1][-]{section.1.6}{Small RNA sequencing protocol}{chapter.1}% 11
\BOOKMARK [0][-]{chapter.2}{Hydro-tRNAseq}{}% 12
\BOOKMARK [1][-]{section.2.1}{Experimental innovation}{chapter.2}% 13
\BOOKMARK [1][-]{section.2.2}{Bioinformatics analysis pipeline}{chapter.2}% 14
\BOOKMARK [2][-]{subsection.2.2.1}{Hierarchical sequence read mapping}{section.2.2}% 15
\BOOKMARK [2][-]{subsection.2.2.2}{tRNA gene annotation}{section.2.2}% 16
\BOOKMARK [1][-]{section.2.3}{Pipeline outputs}{chapter.2}% 17
\BOOKMARK [2][-]{subsection.2.3.1}{Mature tRNA alignment}{section.2.3}% 18
\BOOKMARK [2][-]{subsection.2.3.2}{Pre-tRNA alignment}{section.2.3}% 19
\BOOKMARK [1][-]{section.2.4}{Need for pre-tRNA enrichment}{chapter.2}% 20
\BOOKMARK [1][-]{section.2.5}{PAR-CLIP methodology for the study or RNA-RBP interactions}{chapter.2}% 21
\BOOKMARK [1][-]{section.2.6}{SSB PAR-CLIP}{chapter.2}% 22
\BOOKMARK [1][-]{section.2.7}{tRNA gene annotation}{chapter.2}% 23
\BOOKMARK [1][-]{section.2.8}{Applications and biological insights}{chapter.2}% 24
\BOOKMARK [2][-]{subsection.2.8.1}{tRNA gene abundance does not correlate with tRNA gene count on the isotype level}{section.2.8}% 25
\BOOKMARK [2][-]{subsection.2.8.2}{tRNA gene abundance does not correlate with tRNA gene count on the isoacceptor level}{section.2.8}% 26
\BOOKMARK [1][-]{section.2.9}{Mature tRNA abundance does not correlate with pre-tRNA abundance}{chapter.2}% 27
\BOOKMARK [1][-]{section.2.10}{tRNA transcription initiation and termination}{chapter.2}% 28
\BOOKMARK [1][-]{section.2.11}{Ribonucleotide modifications}{chapter.2}% 29
\BOOKMARK [1][-]{section.2.12}{Annotation of intron-containing tRNA genes}{chapter.2}% 30
\BOOKMARK [1][-]{section.2.13}{CLP1}{chapter.2}% 31
\BOOKMARK [1][-]{section.2.14}{CLP1 figures}{chapter.2}% 32
\BOOKMARK [2][-]{subsection.2.14.1}{Plausible pathomechanisms of CLP1 mutations}{section.2.14}% 33
\BOOKMARK [2][-]{subsection.2.14.2}{hydro-tRNAseq on CLP1}{section.2.14}% 34
\BOOKMARK [1][-]{section.2.15}{tRNA enzyme screen}{chapter.2}% 35
\BOOKMARK [1][-]{section.2.16}{Comparison with other methods}{chapter.2}% 36
\BOOKMARK [1][-]{section.2.17}{Discussion}{chapter.2}% 37
\BOOKMARK [1][-]{section.2.18}{Summary}{chapter.2}% 38
\BOOKMARK [0][-]{chapter.3}{Materials and methods}{}% 39
\BOOKMARK [1][-]{section.3.1}{Hydro-tRNAseq}{chapter.3}% 40
\BOOKMARK [1][-]{section.3.2}{SSB PAR-CLIP}{chapter.3}% 41
\BOOKMARK [1][-]{section.3.3}{Bioinformatic analysis}{chapter.3}% 42
\BOOKMARK [1][-]{section.3.4}{Accession codes}{chapter.3}% 43
\BOOKMARK [0][-]{chapter.4}{C3PO}{}% 44
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 45
\BOOKMARK [1][-]{section.4.2}{From manny}{chapter.4}% 46
\BOOKMARK [1][-]{section.4.3}{TSN binds tRNAs}{chapter.4}% 47
\BOOKMARK [1][-]{section.4.4}{C3PO possesses a length- and structure-dependent endonucleolytic activity}{chapter.4}% 48
\BOOKMARK [1][-]{section.4.5}{Biochemical characterization of C3PO\220s tRNA processing activity}{chapter.4}% 49
\BOOKMARK [1][-]{section.4.6}{Functional validation of C3PO\220s targets}{chapter.4}% 50
\BOOKMARK [1][-]{section.4.7}{C3PO sumary report 2014}{chapter.4}% 51
\BOOKMARK [1][-]{section.4.8}{C3PO summary from annual report 2015}{chapter.4}% 52
\BOOKMARK [1][-]{section.4.9}{C3PO summary from annual report 2016}{chapter.4}% 53
\BOOKMARK [0][-]{chapter.5}{Things that didn't work}{}% 54
\BOOKMARK [0][-]{chapter*.49}{References}{}% 55
